Report Detail
Global (United States, European Union and China) Hepatitis C Virus (HCV) Antiviral Market Research Report 2019-2025
- RnM3656906 |
- 08 August, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Chemical & Material
Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests. According to World Health Organization (WHO), globally 130 million to 150 million people are suffering from chronic hepatitis C. Hepatitis C is treated with antiviral drugs to inhibit the growth of virus and prevent liver damage. According to World Health Organization (WHO), 50% to 90% of people suffering from hepatitis C are treated with antiviral treatment.
In 2019, the market size of Hepatitis C Virus (HCV) Antiviral is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hepatitis C Virus (HCV) Antiviral.
This report studies the global market size of Hepatitis C Virus (HCV) Antiviral, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Hepatitis C Virus (HCV) Antiviral production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Roche Diagnostics
Abbott
Siemens
Qiagen
bioMérieux
Bio-Rad Laboratories
Meridian Bioscience
Vista Diagnostics
Biogate Laboratories
J.Mitra & Co. Ltd
Siemens Medical
General Biologicals
Market Segment by Product Type
HCV Antibody
HCV Viral Load
HCV Genotyping
Market Segment by Application
Diagnostic Centers
Hospitals
Home Use
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Hepatitis C Virus (HCV) Antiviral status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Hepatitis C Virus (HCV) Antiviral manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Hepatitis C Virus (HCV) Antiviral are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Type (2019-2025)
- 1.3.2 HCV Antibody
- 1.3.3 HCV Viral Load
- 1.3.4 HCV Genotyping
- 1.4 Market Segment by Application
- 1.4.1 Global Hepatitis C Virus (HCV) Antiviral Market Share by Application (2019-2025)
- 1.4.2 Diagnostic Centers
- 1.4.3 Hospitals
- 1.4.4 Home Use
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Hepatitis C Virus (HCV) Antiviral Production Value 2014-2025
- 2.1.2 Global Hepatitis C Virus (HCV) Antiviral Production 2014-2025
- 2.1.3 Global Hepatitis C Virus (HCV) Antiviral Capacity 2014-2025
- 2.1.4 Global Hepatitis C Virus (HCV) Antiviral Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Hepatitis C Virus (HCV) Antiviral Market Size CAGR of Key Regions
- 2.2.2 Global Hepatitis C Virus (HCV) Antiviral Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Hepatitis C Virus (HCV) Antiviral Capacity by Manufacturers
- 3.1.2 Global Hepatitis C Virus (HCV) Antiviral Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Hepatitis C Virus (HCV) Antiviral Revenue by Manufacturers (2014-2019)
- 3.2.2 Hepatitis C Virus (HCV) Antiviral Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Hepatitis C Virus (HCV) Antiviral Market Concentration Ratio (CR5 and HHI)
- 3.3 Hepatitis C Virus (HCV) Antiviral Price by Manufacturers
- 3.4 Key Manufacturers Hepatitis C Virus (HCV) Antiviral Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Hepatitis C Virus (HCV) Antiviral Market
- 3.6 Key Manufacturers Hepatitis C Virus (HCV) Antiviral Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 HCV Antibody Production and Production Value (2014-2019)
- 4.1.2 HCV Viral Load Production and Production Value (2014-2019)
- 4.1.3 HCV Genotyping Production and Production Value (2014-2019)
- 4.2 Global Hepatitis C Virus (HCV) Antiviral Production Market Share by Type
- 4.3 Global Hepatitis C Virus (HCV) Antiviral Production Value Market Share by Type
- 4.4 Hepatitis C Virus (HCV) Antiviral Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Hepatitis C Virus (HCV) Antiviral Consumption by Application
6 Production by Regions
- 6.1 Global Hepatitis C Virus (HCV) Antiviral Production (History Data) by Regions 2014-2019
- 6.2 Global Hepatitis C Virus (HCV) Antiviral Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Hepatitis C Virus (HCV) Antiviral Production Growth Rate 2014-2019
- 6.3.2 United States Hepatitis C Virus (HCV) Antiviral Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Hepatitis C Virus (HCV) Antiviral Import & Export
- 6.4 European Union
- 6.4.1 European Union Hepatitis C Virus (HCV) Antiviral Production Growth Rate 2014-2019
- 6.4.2 European Union Hepatitis C Virus (HCV) Antiviral Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Hepatitis C Virus (HCV) Antiviral Import & Export
- 6.5 China
- 6.5.1 China Hepatitis C Virus (HCV) Antiviral Production Growth Rate 2014-2019
- 6.5.2 China Hepatitis C Virus (HCV) Antiviral Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Hepatitis C Virus (HCV) Antiviral Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Hepatitis C Virus (HCV) Antiviral Consumption by Regions
- 7.1 Global Hepatitis C Virus (HCV) Antiviral Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Hepatitis C Virus (HCV) Antiviral Consumption by Type
- 7.2.2 United States Hepatitis C Virus (HCV) Antiviral Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Hepatitis C Virus (HCV) Antiviral Consumption by Type
- 7.3.2 European Union Hepatitis C Virus (HCV) Antiviral Consumption by Application
- 7.4 China
- 7.4.1 China Hepatitis C Virus (HCV) Antiviral Consumption by Type
- 7.4.2 China Hepatitis C Virus (HCV) Antiviral Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Hepatitis C Virus (HCV) Antiviral Consumption by Type
- 7.5.2 Rest of World Hepatitis C Virus (HCV) Antiviral Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Roche Diagnostics
- 8.1.1 Roche Diagnostics Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
- 8.1.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
- 8.1.5 Roche Diagnostics Recent Development
- 8.2 Abbott
- 8.2.1 Abbott Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
- 8.2.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
- 8.2.5 Abbott Recent Development
- 8.3 Siemens
- 8.3.1 Siemens Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
- 8.3.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
- 8.3.5 Siemens Recent Development
- 8.4 Qiagen
- 8.4.1 Qiagen Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
- 8.4.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
- 8.4.5 Qiagen Recent Development
- 8.5 bioMérieux
- 8.5.1 bioMérieux Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
- 8.5.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
- 8.5.5 bioMérieux Recent Development
- 8.6 Bio-Rad Laboratories
- 8.6.1 Bio-Rad Laboratories Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
- 8.6.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
- 8.6.5 Bio-Rad Laboratories Recent Development
- 8.7 Meridian Bioscience
- 8.7.1 Meridian Bioscience Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
- 8.7.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
- 8.7.5 Meridian Bioscience Recent Development
- 8.8 Vista Diagnostics
- 8.8.1 Vista Diagnostics Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
- 8.8.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
- 8.8.5 Vista Diagnostics Recent Development
- 8.9 Biogate Laboratories
- 8.9.1 Biogate Laboratories Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
- 8.9.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
- 8.9.5 Biogate Laboratories Recent Development
- 8.10 J.Mitra & Co. Ltd
- 8.10.1 J.Mitra & Co. Ltd Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
- 8.10.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
- 8.10.5 J.Mitra & Co. Ltd Recent Development
- 8.11 Siemens Medical
- 8.12 General Biologicals
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Hepatitis C Virus (HCV) Antiviral Capacity, Production Forecast 2019-2025
- 9.1.2 Global Hepatitis C Virus (HCV) Antiviral Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Hepatitis C Virus (HCV) Antiviral Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Hepatitis C Virus (HCV) Antiviral Production Forecast by Type
- 9.7.2 Global Hepatitis C Virus (HCV) Antiviral Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Hepatitis C Virus (HCV) Antiviral Sales Channels
- 10.2.2 Hepatitis C Virus (HCV) Antiviral Distributors
- 10.3 Hepatitis C Virus (HCV) Antiviral Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Hepatitis C Virus (HCV) Antiviral . Industry analysis & Market Report on Hepatitis C Virus (HCV) Antiviral is a syndicated market report, published as Global (United States, European Union and China) Hepatitis C Virus (HCV) Antiviral Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Hepatitis C Virus (HCV) Antiviral market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
